Process for manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholine
TW202039488A
Methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate active compound product having improved properties, production and formulation thereof
US2019371469A1
Method of Identifying a Subgroup of Patients Suffering from DcSSc which Benefits from a Treatment with sGC Stimulators and sGC Activators in a Higher Degree than a Control Group
TN2014000227A1
Method for producing substituted 5-fluoro-1h-pyrazolopyridines
AU2014220801A1
Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
CA3040720A1
Method for producing substituted 5-fluoro-1h-pyrazolopyridines
AU2011212521A1
sGC stimulators or sGC activators alone and in combination with PDE5 inhbitors for the treatment of Cystic Fibrosis
EP3415515A1
Method for the preparation of methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate
